936 results on '"Lee, Yena"'
Search Results
202. Antidepressant Medications and Weight Change: A Narrative Review
203. Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and network meta-analysis
204. Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials
205. Deficits of social cognition in bipolar disorder: Systematic review and meta‐analysis.
206. Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?
207. Mental health conditions among the general population, healthcare workers and quarantined population during the coronavirus disease 2019 (COVID-19) pandemic.
208. The emerging role of psilocybin and MDMA in the treatment of mental illness
209. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE
210. hzVSF, a novel HBV therapeutic candidate, shows WHsAg loss in woodchuck hepatitis model and safety in phase I clinical study
211. Synergistic effect of social media use and psychological distress on depression in China during the COVID ‐19 epidemic
212. The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder
213. The Mental Health Effects of COVID-19 on Health Care Providers in China
214. Efficacy and safety of parenteral vitamin D therapy in infants and children with vitamin D deficiency caused by intestinal malabsorption
215. Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency
216. The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
217. Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
218. Functional Characteristics of Novel FGFR1 Mutations in Patients with Isolated Gonadotropin-Releasing Hormone Deficiency
219. Preventing suicide in the context of the COVID‐19 pandemic
220. The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study
221. Disparities in the Development and Implementation of Guidelines for the Management of Depression in Adults
222. Correction
223. Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
224. MON-096 Endocrine Complications Following Cancer Treatment in Survivors of Pediatric Solid Tumors: 18 Years’ Experience of a Single Academic Center
225. SUN-074 Loss-Of-Function Mutations in GATA4 in Patients with 46,XY Disorders of Sex Development Without Cardiac Defects
226. High Diagnostic Yield and Clinical Utility of Whole Exome Sequencing Using an Automated Variant Prioriti S Ation System, EVIDENCE, for Patients with Suspected Genetic Disorders
227. Carbon fiber based microeletrode with biodegradable silk for in vivo neural recording
228. Identification of Potocki–Lupski syndrome in patients with developmental delay and growth failure
229. Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence
230. The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid Dataset
231. Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation
232. Functional Characteristics of Novel FGFR1 Mutations in Patients with Isolated Gonadotropin-Releasing Hormone Deficiency.
233. Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression.
234. The sulfur formation system mediating extracellular cysteine‐cystine recycling in Fervidobacterium islandicum AW‐1 is associated with keratin degradation.
235. Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.
236. A Study on the Perceptual Mismatches between Learners and Teachers on Evaluation of Academic Presentation
237. Machine learning based Android malware classification
238. Parsing metabolic heterogeneity in mood disorders: A hypothesis‐driven cluster analysis of glucose and insulin abnormalities
239. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial
240. Effort-based decision-making is affected by overweight/obesity in major depressive disorder
241. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression
242. Antidepressants Reduced Risk of Mortality in Patients With Diabetes Mellitus: A Population-Based Cohort Study in Taiwan
243. Stress, epigenetics and depression: A systematic review
244. Prussian blue-decorated Cs ion exchange resins with polydopamine as a linker
245. Antipsychotic use is inversely associated with gastric cancer risk: A nationwide population‐based nested case‐control study
246. Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
247. Characterizing the gut microbiota in adults with bipolar disorder: a pilot study
248. Risk of Dementia Among Individuals With Psoriasis
249. Pilot study of EVIDENCE: High diagnostic yield and clinical utility of whole exome sequencing using an automated interpretation system for patients with suspected genetic disorders
250. Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.